Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT00576654
Title Veliparib and Irinotecan Hydrochloride in Treating Patients With Cancer That Is Metastatic or Cannot Be Removed by Surgery
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors National Cancer Institute (NCI)

triple-receptor negative breast cancer

Hodgkin's lymphoma

non-Hodgkin lymphoma

Advanced Solid Tumor




Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Yale University New Haven Connecticut 06520 United States Details
University of Maryland/Greenebaum Cancer Center Baltimore Maryland 21201 United States Details
Dana-Farber Cancer Institute Boston Massachusetts 02215 United States Details
Wayne State University/Karmanos Cancer Institute Detroit Michigan 48201 United States Details
Covenant Medical Center Harrison Saginaw Michigan 48602 United States Details
*Shaded cells indicate that there was no data available from for the field